Matches in SemOpenAlex for { <https://semopenalex.org/work/W2467053533> ?p ?o ?g. }
- W2467053533 endingPage "151" @default.
- W2467053533 startingPage "115" @default.
- W2467053533 abstract "To study hepatic cytolysis in patients treated by highly active antiretroviral therapy (HAART) with protease inhibitor or with two nucleoside reverse transcriptase inhibitors (NRTIs).We selected patients of the Aquitaine Cohort who initiated HAART or two NRTIs before 1 January 1998, had alanine amino-transferase (ALT) < or = 200 IU/I at baseline and at least one follow-up measure. Cox model was used to study the association between occurrence of severe hepatic cytolysis (ALT>200 IU/l) and age, gender, HIV transmission group, baseline CD4 and CD8 cell count, history of hepatic cytolysis, antiretroviral drug, baseline liver enzymes (WHO classification level 0: < or = 50 IU/l, level 1: 51 to 100, level 2: 101 to 200), hepatitis B and C co-infection.Sixty-four of 748 (8.5%) patients treated with HAART and 71 of 1249 (5.7%) treated with two NRTIs developed cytolysis. The probability of occurrence was 7.9% after 1 year [95% confidence interval (CI), 5.9-10.4] for patients treated with HAART and 4.8% (95% CI, 3.6-6.4) for patients treated with two NRTIs (log-rank test, P = 0.01). The median time to occurrence was 164 days for HAART-treated patients and 252 days for those treated with two NRTIs. In multivariate analysis, the history of cytolysis [hazard ratio (HR) = 2.3; 95% CI, 1.2-4.4], baseline value of ALT (HR = 2.4; 95% CI, 1.2-4.8 and HR = 3.3; 95% CI, 1.4-7.4 for levels 1 and 2, respectively), hepatitis B (HR = 3.0; 95% CI, 1.4-6.2) and C co-infections (HR = 3.2; 95% CI, 1.7-6.2) remained significantly associated with the occurrence of severe hepatic cytolysis among HAART-treated patients. History of cytolysis, hepatitis B and C were associated with cytolysis in patients treated with two NRTIs (HR = 14.8, 2.6 and 2.7, respectively).Hepatic cytolysis is more frequent among patients treated with HAART than with two NRTIs. Hepatitis B and C are the major risk factors after initiation of HAART or treatment with NRTIs. Co-infections with hepatitis B virus or hepatitis C virus may modify the management of HIV-infected patients treated by HAART." @default.
- W2467053533 created "2016-07-22" @default.
- W2467053533 creator A5029949167 @default.
- W2467053533 creator A5049440373 @default.
- W2467053533 creator A5055633429 @default.
- W2467053533 creator A5056641569 @default.
- W2467053533 creator A5059851527 @default.
- W2467053533 creator A5068189328 @default.
- W2467053533 creator A5078599198 @default.
- W2467053533 creator A5078695748 @default.
- W2467053533 creator A5091017886 @default.
- W2467053533 date "1999-12-01" @default.
- W2467053533 modified "2023-10-10" @default.
- W2467053533 title "Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998" @default.
- W2467053533 cites W1980363740 @default.
- W2467053533 cites W1980832389 @default.
- W2467053533 cites W1993539838 @default.
- W2467053533 cites W1997047331 @default.
- W2467053533 cites W2008383946 @default.
- W2467053533 cites W2037756744 @default.
- W2467053533 cites W2060137807 @default.
- W2467053533 cites W2082790827 @default.
- W2467053533 cites W2084659448 @default.
- W2467053533 cites W2120400009 @default.
- W2467053533 cites W2131196141 @default.
- W2467053533 cites W2155449170 @default.
- W2467053533 cites W2162325574 @default.
- W2467053533 cites W2318289184 @default.
- W2467053533 cites W2412720604 @default.
- W2467053533 doi "https://doi.org/10.1097/00002030-199912030-00002" @default.
- W2467053533 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10597772" @default.
- W2467053533 hasPublicationYear "1999" @default.
- W2467053533 type Work @default.
- W2467053533 sameAs 2467053533 @default.
- W2467053533 citedByCount "128" @default.
- W2467053533 countsByYear W24670535332012 @default.
- W2467053533 countsByYear W24670535332013 @default.
- W2467053533 countsByYear W24670535332014 @default.
- W2467053533 countsByYear W24670535332016 @default.
- W2467053533 countsByYear W24670535332017 @default.
- W2467053533 countsByYear W24670535332020 @default.
- W2467053533 countsByYear W24670535332022 @default.
- W2467053533 crossrefType "journal-article" @default.
- W2467053533 hasAuthorship W2467053533A5029949167 @default.
- W2467053533 hasAuthorship W2467053533A5049440373 @default.
- W2467053533 hasAuthorship W2467053533A5055633429 @default.
- W2467053533 hasAuthorship W2467053533A5056641569 @default.
- W2467053533 hasAuthorship W2467053533A5059851527 @default.
- W2467053533 hasAuthorship W2467053533A5068189328 @default.
- W2467053533 hasAuthorship W2467053533A5078599198 @default.
- W2467053533 hasAuthorship W2467053533A5078695748 @default.
- W2467053533 hasAuthorship W2467053533A5091017886 @default.
- W2467053533 hasBestOaLocation W24670535331 @default.
- W2467053533 hasConcept C120665830 @default.
- W2467053533 hasConcept C121332964 @default.
- W2467053533 hasConcept C126322002 @default.
- W2467053533 hasConcept C154317977 @default.
- W2467053533 hasConcept C201903717 @default.
- W2467053533 hasConcept C202751555 @default.
- W2467053533 hasConcept C203014093 @default.
- W2467053533 hasConcept C207103383 @default.
- W2467053533 hasConcept C2776452011 @default.
- W2467053533 hasConcept C2777351918 @default.
- W2467053533 hasConcept C2778606649 @default.
- W2467053533 hasConcept C2780727368 @default.
- W2467053533 hasConcept C3013748606 @default.
- W2467053533 hasConcept C44249647 @default.
- W2467053533 hasConcept C55493867 @default.
- W2467053533 hasConcept C61511704 @default.
- W2467053533 hasConcept C71924100 @default.
- W2467053533 hasConcept C72563966 @default.
- W2467053533 hasConcept C73588182 @default.
- W2467053533 hasConcept C86803240 @default.
- W2467053533 hasConcept C88879693 @default.
- W2467053533 hasConcept C90924648 @default.
- W2467053533 hasConceptScore W2467053533C120665830 @default.
- W2467053533 hasConceptScore W2467053533C121332964 @default.
- W2467053533 hasConceptScore W2467053533C126322002 @default.
- W2467053533 hasConceptScore W2467053533C154317977 @default.
- W2467053533 hasConceptScore W2467053533C201903717 @default.
- W2467053533 hasConceptScore W2467053533C202751555 @default.
- W2467053533 hasConceptScore W2467053533C203014093 @default.
- W2467053533 hasConceptScore W2467053533C207103383 @default.
- W2467053533 hasConceptScore W2467053533C2776452011 @default.
- W2467053533 hasConceptScore W2467053533C2777351918 @default.
- W2467053533 hasConceptScore W2467053533C2778606649 @default.
- W2467053533 hasConceptScore W2467053533C2780727368 @default.
- W2467053533 hasConceptScore W2467053533C3013748606 @default.
- W2467053533 hasConceptScore W2467053533C44249647 @default.
- W2467053533 hasConceptScore W2467053533C55493867 @default.
- W2467053533 hasConceptScore W2467053533C61511704 @default.
- W2467053533 hasConceptScore W2467053533C71924100 @default.
- W2467053533 hasConceptScore W2467053533C72563966 @default.
- W2467053533 hasConceptScore W2467053533C73588182 @default.
- W2467053533 hasConceptScore W2467053533C86803240 @default.
- W2467053533 hasConceptScore W2467053533C88879693 @default.
- W2467053533 hasConceptScore W2467053533C90924648 @default.
- W2467053533 hasIssue "17" @default.